Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 503

Similar articles for PubMed (Select 10838664)

1.

Restoration of alloreactivity of melanoma by transduction with B7.1.

Brady MS, Lee F, Eckels DD, Ree SY, Latouche JB, Lee JS.

J Immunother. 2000 May-Jun;23(3):353-61.

PMID:
10838664
2.
3.

Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.

Wilson JL, Cunningham AC, Kirby JA.

Immunology. 1995 Nov;86(3):325-30.

5.

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Koulova L, Clark EA, Shu G, Dupont B.

J Exp Med. 1991 Mar 1;173(3):759-62.

6.
8.

CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.

Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P.

Cancer Res. 2003 Jun 1;63(11):2836-43.

9.

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.

Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA.

Int J Cancer. 1994 Jul 1;58(1):69-79.

PMID:
7516926
10.
11.
12.

Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors.

Boxhorn HK, Smith JG, Chang YJ, Guerry D, Lee WM, Rodeck U, Turka LA, Eck SL.

Cancer Immunol Immunother. 1998 Jul;46(5):283-92.

PMID:
9690457
13.
14.

A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.

Sulé-Suso J, Arienti F, Melani C, Colombo MP, Parmiani G.

Eur J Immunol. 1995 Oct;25(10):2737-42.

PMID:
7589065
15.

Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro.

Habicht A, Lindauer M, Galmbacher P, Rudy W, Gebert J, Schackert HK, Meuer SC, Moebius U.

Eur J Cancer. 1995 Dec;31A(13-14):2396-402.

PMID:
8652275
16.

Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes.

Mazzocchi A, Melani C, Rivoltini L, Castelli C, Del Vecchio M, Lombardo C, Colombo MP, Parmiani G.

Cancer Immunol Immunother. 2001 Jun;50(4):199-211.

PMID:
11459172
18.
19.

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.

Galea-Lauri J, Darling D, Gan SU, Krivochtchapov L, Kuiper M, Gäken J, Souberbielle B, Farzaneh F.

J Immunol. 1999 Jul 1;163(1):62-70.

20.

Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.

Alexander MA, Bennicelli J, Guerry D 4th.

J Immunol. 1989 Jun 1;142(11):4070-8.

PMID:
2469732
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk